On Friday, Ocugen Inc (OCGN) stock saw a modest uptick, ending the day at $0.71 which represents no change from the prior close of of $0.71. The stock opened at $0.72 and touched a low of $0.7 during ...

On Thursday, Ocugen Inc (OCGN) stock saw a decline, ending the day at $0.71 which represents a decrease of $-0.02 or -2.74% from the prior close of $0.73. The stock opened at $0.74 and touched a low ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

As of 18 December at 11:20:41 am GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

As of 3 January at 2:44:56 pm GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

MALVERN, Pa., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and ...

“We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but preliminary efficacy data as the study progresses,” said Dr. Huma Qamar, Chief ...

Ocugen (OCGN) announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema, DME. “OCU200 has the potential to change the treatment landscape ...